483
Boehringer Ingelheim RCV GmbH & Co KGBoehringer Ingelheim RCV GmbH & Co KG – FDA 483, Nov 19, 2018
Record Details
An FDA inspection of Boehringer Ingelheim RCV GmbH & Co KG in Vienna, Austria, identified inadequate process equipment. Specifically, the firm's scraping practices introduced foreign particles into process intermediates, indicating a deficiency in maintaining equipment surfaces. This issue could compromise the quality of drug substances produced.
View Company Profile
ID · e25819fd-f705-497d-90d5-9e3e164ead31
Other documents for Boehringer Ingelheim RCV GmbH & Co KG
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.